Wednesday, April 27, 2016 10:25:54 AM
MicroVision, Inc. (NASDAQ:MVIS), a leader in innovative ultra-miniature projection display and imaging technology, today announced its financial and operating results for the first quarter of 2016 marked by significant year-over-year and sequential revenue growth.
MicroVision recorded its highest quarterly product and royalty revenue to date. MicroVision’s revenue in the first quarter 2016 was up 311 percent from the same quarter last year and 100 percent from the fourth quarter of 2015. Gross margin for the period of 30 percent was a significant improvement from the negative gross margin the company reported in the first quarter last year.
The following financial results are for the three months ended March 31, 2016, compared to the three months ended March 31, 2015.
• Revenue was $3.7 million compared to $0.9 million one year ago.
• Operating loss was $3.6 million, compared to a loss of $4.0 million for the same quarter one year ago.
• Net loss was $3.6 million, or $0.07 per share, compared to a loss of $4.0 million, or $0.09 per share for the same quarter one year ago.
• In the first quarter 2016 cash used in operations was $3.0 million compared to cash provided by operations of $5.1 million for the same period in 2015. Cash flow in the first quarter 2015 included the receipt of an $8 million license payment.
As of March 31, 2016, backlog was $9.2 million and cash and cash equivalents were $11.2 million. The cash balance includes funds received during the quarter of approximately $6.3 million from an offering of the company’s common stock.
You can lead a horse to water. But you can't make him get down on one knee and do an Al Jolson impression!
Recent MVIS News
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 03/05/2024 01:42:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:18:06 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/05/2024 01:10:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:15:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:15:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:15:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:15:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:15:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:15:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:14:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 09:15:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 02:26:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 10:30:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 10:30:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 10:30:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 10:30:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 10:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 10:30:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 09:35:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 01:11:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:20:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:37:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:15:50 PM
- Hot Take: A Unique Earnings Play • AllPennyStocks.com • 11/08/2023 02:35:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 08:30:53 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM